PRINCETON, N.J. — Sandoz on Thursday launched telmisartan tablets, the generic version of Micardis from Boehringer Ingelheim. The drug is used to treat hypertension, the company said. One-in-three adults over the age of 20 years old has hypertension, Sandoz noted, citing a study from the Centers for Disease Control and Prevention.
“We look forward to expanding access by providing a high-quality and affordable alternative to the millions of Americans affected by hypertension," said Peter Goldschmidt, president of Sandoz.
Sales for branded telmisartan tablets were $174 million for the year ending December 2014, according to data from IMS Health. Sandoz will market the tablets in 20-, 40- and 80-mg dosage strengths.